Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease

Ming-Chang Chiang1, Hui-Mei Chen, Yi-Hsin Lee

  • 1Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei, Taiwan.

Human Molecular Genetics
|January 11, 2007
PubMed

Insights

Huntington's disease (HD) involves urea cycle deficiency and ammonia toxicity, worsening neurological symptoms. Protein-restricted diets improved urea cycle function, reduced ammonia, and ameliorated HD symptoms in mouse models.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene.
  • Urea cycle deficiency, marked by hyperammonemia, is a significant feature in HD mouse models.

Purpose of the Study:

  • To investigate the role of urea cycle deficiency in HD pathogenesis.
  • To explore the impact of mutant Huntingtin (Htt) on urea cycle enzyme regulation.
  • To evaluate the therapeutic potential of dietary interventions for HD.

Main Methods:

  • Utilized two mouse models of Huntington's disease.
  • Assessed urea cycle enzyme activity, ammonia levels, and C/EBPalpha transcription factor function.
  • Examined the interaction between mutant Htt, C/EBPalpha, and cofactors.
  • Investigated the effects of protein-restricted diets on HD pathology and symptoms.

Main Results:

  • HD mouse models exhibit urea cycle deficiency and hyperammonemia, potentially exacerbating neurological deficits.
  • Mutant Htt impairs C/EBPalpha function by disrupting cofactor interaction and promoting aggregation.
  • Protein-restricted diets restored C/EBPalpha activity, repaired urea cycle deficiency, reduced hyperammonemia, and improved motor function and Htt aggregate formation in HD mice.

Conclusions:

  • Urea cycle deficiency is a key pathological feature in HD, driven by impaired C/EBPalpha function due to mutant Htt.
  • Targeting urea cycle repair and ammonia detoxification presents a promising therapeutic strategy for Huntington's disease.
  • Dietary protein restriction demonstrates efficacy in ameliorating HD pathology and symptoms in preclinical models.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Urea Cycle01:23

Urea Cycle

The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...